Nuvectis Pharma, Inc. - COM (NVCT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2022 to Q4 2025

Type / Class
Equity / COM
Symbol
NVCT on Nasdaq
Price per share
$8.85
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,940,727
Total reported value
$29,779,542
% of total 13F portfolios
0%
Share change
+542,025
Value change
+$4,250,653
Number of holders
37
Price from insider filings
$8.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 37 institutional investors reported holding 3,940,727 shares of Nuvectis Pharma, Inc. - COM (NVCT).

Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,940,727 $29,779,542 +$4,250,653 $7.55 37
2025 Q3 3,694,801 $22,240,671 +$875,366 $6.02 52
2025 Q2 3,242,656 $24,212,274 +$8,414,990 $7.47 46
2025 Q1 2,047,125 $20,049,463 +$7,527,323 $9.77 33
2024 Q4 1,320,778 $7,145,290 +$1,393,786 $5.41 31
2024 Q3 1,049,389 $6,599,330 -$771,215 $6.29 31
2024 Q2 1,205,075 $7,627,698 -$2,433,916 $6.33 40
2024 Q1 1,561,977 $12,807,385 +$393,490 $8.20 40
2023 Q4 1,513,319 $12,620,464 +$1,886,095 $8.34 36
2023 Q3 1,277,304 $16,463,587 +$85,915 $12.89 33
2023 Q2 1,252,927 $20,033,227 +$12,444,259 $15.97 37
2023 Q1 483,928 $6,343,634 -$3,188,708 $13.11 13
2022 Q4 983,925 $7,378,970 +$968,656 $7.50 11
2022 Q3 1,417,003 $10,047,000 +$5,345,357 $7.09 9
2022 Q2 643,014 $7,201,000 +$370,284 $11.20 10
2022 Q1 628,110 $4,654,000 +$4,654,000 $7.40 7